Literature DB >> 10487891

Protein encapsulation within poly(ethylene glycol)-coated nanospheres. II. Controlled release properties.

P Quellec1, R Gref, E Dellacherie, F Sommer, M D Tran, M J Alonso.   

Abstract

The development of injectable nanoparticulate "stealth" carriers for protein delivery is a major challenge. The aim of this work was to investigate the possibility of achieving the controlled release of a model protein, human serum albumin (HSA), from poly(ethylene glycol) (PEG)-coated biodegradable nanospheres (mean diameter of about 200 nm) prepared from amphiphilic diblock PEG-poly(lactic acid) (PLA) copolymers. HSA was efficiently incorporated into the nanospheres, reaching loadings as high as 9% (w/w). Results of the in vitro release studies showed that it is possible to control the HSA release by choosing the appropriate nanosphere size, loading, and composition. These results also revealed that, following their release, HSA molecules readsorbed onto the nanospheres surfaces when they were not protected by a PEG coating. We were surprised to observe that in spite of the water uptake of the PLA-PEG nanospheres [11-29% (w/w)], the copolymer did not significantly degrade after a 15-day incubation period. Therefore, we concluded that during this time HSA release from PLA-PEG nanospheres followed a diffusion mechanism where bulk erosion and surface desorption were negligible. Copyright 1999 John Wiley & Sons, Inc.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10487891     DOI: 10.1002/(sici)1097-4636(19991205)47:3<388::aid-jbm14>3.0.co;2-v

Source DB:  PubMed          Journal:  J Biomed Mater Res        ISSN: 0021-9304


  10 in total

Review 1.  Drug transport to brain with targeted nanoparticles.

Authors:  Jean-Christophe Olivier
Journal:  NeuroRx       Date:  2005-01

2.  Removal of polyethylene glycols from protein samples using titanium dioxide.

Authors:  Cheng Zhao; Peter B O'Connor
Journal:  Anal Biochem       Date:  2007-03-25       Impact factor: 3.365

3.  Influence of preparation conditions on acyclovir-loaded poly-d,l-lactic acid nanospheres and effect of PEG coating on ocular drug bioavailability.

Authors:  Claudia Giannavola; Claudio Bucolo; Adriana Maltese; Donatella Paolino; Maria Angela Vandelli; Giovanni Puglisi; Vinecent H L Lee; Massimo Fresta
Journal:  Pharm Res       Date:  2003-04       Impact factor: 4.200

4.  Cationic surface modification of PLG nanoparticles offers sustained gene delivery to pulmonary epithelial cells.

Authors:  Abdulgader Baoum; Navneet Dhillon; Shilpa Buch; Cory Berkland
Journal:  J Pharm Sci       Date:  2010-05       Impact factor: 3.534

5.  Nanoparticles based on a hydrophilic polyester with a sheddable PEG coating for protein delivery.

Authors:  Neda Samadi; Mies J van Steenbergen; Joep B van den Dikkenberg; Tina Vermonden; Cornelus F van Nostrum; Maryam Amidi; Wim E Hennink
Journal:  Pharm Res       Date:  2014-03-14       Impact factor: 4.200

6.  OX26 modified hyperbranched polyglycerol-conjugated poly(lactic-co-glycolic acid) nanoparticles: synthesis, characterization and evaluation of its brain delivery ability.

Authors:  Hanmei Bao; Xu Jin; Ling Li; Feng Lv; Tianjun Liu
Journal:  J Mater Sci Mater Med       Date:  2012-05-09       Impact factor: 3.896

7.  RES-loaded pegylated CS NPs: for efficient ocular delivery.

Authors:  Saravanakumar Pandian; Vinoth Jeevanesan; Chandrasekar Ponnusamy; Subramanian Natesan
Journal:  IET Nanobiotechnol       Date:  2017-02       Impact factor: 1.847

8.  Assessment of insulin stability inside diblock copolymer PEG-PLA microspheres.

Authors:  Mohamed Abbas Ibrahim
Journal:  Sci Pharm       Date:  2010-06-23

9.  Beta-lapachone-containing PEG-PLA polymer micelles as novel nanotherapeutics against NQO1-overexpressing tumor cells.

Authors:  Elvin Blanco; Erik A Bey; Ying Dong; Brent D Weinberg; Damon M Sutton; David A Boothman; Jinming Gao
Journal:  J Control Release       Date:  2007-04-29       Impact factor: 11.467

10.  One-step surface modification of poly(lactide-co-glycolide) microparticles with heparin.

Authors:  Chengji Cui; Steven P Schwendeman
Journal:  Pharm Res       Date:  2007-08-21       Impact factor: 4.580

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.